| USAN | RINUCUMAB |
|---|---|
| Code Desination | REGN2176 |
| Chemical Name | Immunoglobulin G4-kappa, anti-(human platelet-derived growth factor receptorb (CD140 antigen-like family member B, PDGFR-1, CD140b)); human monoclonal antibody; g4 heavy chain (1-448) [human VH (IGHV4-39*01-(IGHD)-IGHJ5*02) (93%) [10.7.14] (1-122)-IGHG4*01 |
| CAS No. | 1569263-06-4 |
| Formula | C6472H9974N1710O2022S38(peptide) |
| Chemical Structure |
 |
| Mol. Wt. | 145.3 kD |
| Sponsor | Regeneron Pharmaceuticals, Inc. |
| UNII | 10E3O6YI4W |
| WHO No. | 10175 |
| Therapeutic Claim | Treatment of neovascular age-related macular degeneration |
| Added Date | 2014 |
| File | PDF |
Extended Information